{
  "meta": {
    "title": "Obesity_And_Metabolic_Syndrome",
    "url": "https://brainandscalpel.vercel.app/obesity-and-metabolic-syndrome-2b5f2d39.html",
    "scrapedAt": "2025-11-30T14:13:31.851Z"
  },
  "questions": [
    {
      "text": "A 35-year-old woman comes to the emergency department because of intermittent fevers, chills, malaise and fatigue for the past 7 days. The patient recently returned from a safari in Africa. She received chemoprophylaxis with mefloquine during the trip and discontinued it upon returning. Past medical history is significant for seasonal allergies and fibromyalgia. Family history is significant for hypertension in the patient&#8217;s father. Temperature is 38.9&#176;C (102&#176;F), pulse is 103/min, respirations are 18/min, and blood pressure is 118/70 mmHg. Physical examination shows pale conjunctiva. Laboratory evaluation shows mild anemia and thrombocytopenia. Peripheral blood smear results are shown below. Which of the following is the most appropriate treatment option for this patient?<br>&#160; <div><img src=\"https://d16qt3wv6xm098.cloudfront.net/9beddcjjQNCs6ZoMYcX1o86GQFqPk5Jd/_.png\"></div><br><strong><sup>Image reproduced from Wikimedia Commons</sup></strong>",
      "choices": [
        {
          "id": 1,
          "text": "Atovaquone and azithromycin"
        },
        {
          "id": 2,
          "text": "Atovaquone and proguanil"
        },
        {
          "id": 3,
          "text": "Sulfadiazine and pyrimethamine"
        },
        {
          "id": 4,
          "text": "Metronidazole and paromomycin"
        },
        {
          "id": 5,
          "text": "Chloroquine and primaquine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "This patient presents with fever, chills, and myalgias after recent travel to a malaria-endemic region and incomplete chemoprophylaxis. A peripheral blood smear reveals banana-shaped gametocytes. In combination, these findings are concerning for <em>Plasmodium falciparum</em> malaria.<br><br>The first-line treatment options for <strong>chloroquine-resistant malaria</strong> within endemic areas include <strong>artemisinins </strong>(e.g., artemisinin, artesunate, dihydroartemisinin) or <strong>atovaquone and proguanil</strong>, which are well tolerated and have excellent cure rates. Artemisinins should be administered with a <strong>second agent</strong> (e.g., <strong>artemether-lumefantrine</strong>, artesunate-amodiaquine, artesunate-mefloquine) with a longer half-life to prevent the development of artemisinin resistance and provide an extended duration of drug level to clear parasitemia.<br><br>Chloroquine is the treatment of choice for malaria acquired in <strong>chloroquine-sensitive areas</strong> (e.g., Haiti, the Dominican Republic, most regions of the Middle East, and Central America west of the Panama Canal). &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Atovaquone and azithromycin:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Atovaquone and azithromycin are the treatment of choice for babesiosis. The condition is most common in the northeastern United States, and patients present with hemolytic anemia and fever. A peripheral blood smear will reveal merozoites in the shape of a &#8220;Maltese cross&#8221;. In contrast, this patient&#8217;s history and laboratory findings suggest infection by <em>Plasmodium falciparum</em>. &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Atovaquone and proguanil:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Sulfadiazine and pyrimethamine:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Sulfadiazine and pyrimethamine is the treatment of choice for toxoplasmosis. The infection is asymptomatic in immunocompetent patients but can rarely present with mononucleosis-like symptoms. In contrast, this patient&#8217;s history and laboratory findings suggest infection by <em>Plasmodium falciparum</em>. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Metronidazole and paromomycin:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Metronidazole effectively treats <em>Entamoeba histolytica</em>, which can cause dysentery and extraintestinal abscesses in the liver, lung, and brain. Paromomycin can be administered to eliminate residual cysts in the gastrointestinal lumen. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Chloroquine and primaquine:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Most <em>Plasmodium falciparum</em> strains in Africa are resistant to chloroquine. Therefore, alternate agents are required to treat this patient&#8217;s symptoms. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 46-year-old woman presents to the emergency department because of fever, myalgias, and chills for the past two days. The patient does not have cough, dysuria, diarrhea, convulsions, or recent sick contacts. However, she returned from an overseas trip to India around 2-months ago. She had similar symptoms in Nigeria during her first month there, which resolved completely after appropriate treatment. Temperature is 38.9&#176;C (102.0&#176;F), pulse is 103/min, respirations are 18/min, and blood pressure is 118/70 mmHg. Physical examination shows scleral icterus, jaundice, and hepatosplenomegaly. Laboratory results show mild anemia and hyperbilirubinemia. Peripheral blood smear results are shown below. Addition of which of the following to the patient&#8217;s prophylaxis regimen would have helped prevent the development of her current symptoms? <br>&#160;<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/vuEvqinLS6K1vynZZbDXXrTFQbq-g0Si/_.jpg\"></div><br><strong><sup>Image reproduced from Wikimedia Commons</sup></strong>",
      "choices": [
        {
          "id": 1,
          "text": "Chloroquine"
        },
        {
          "id": 2,
          "text": "Arthemether"
        },
        {
          "id": 3,
          "text": "Primaquine"
        },
        {
          "id": 4,
          "text": "Ivermectin"
        },
        {
          "id": 5,
          "text": "Mefloquine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "This patient recently returned from a trip to a malaria-endemic region and most likely acquired a Plasmodium infection. The recurrence of symptoms 2-months later and Schuffner granules' presence in erythrocytes suggest recurrent <em>Plasmodium vivax </em>or<em> Plasmodium ovale</em> parasitemia.<br><br>Unlike <em>Plasmodium falciparum</em>, <em>P. vivax </em>and<em> P. ovale</em> undergo a dormant hepatic phase (hypnozoite stage) that may cause recurrence weeks to months after the initial infection. Patients infected with these strains should be treated with antimalarial agents that target the <strong>erythrocytic stage</strong> (e.g. chloroquine) and hepatic dormant stage (e.g. primaquine), also termed the <strong>non-erythrocytic stage</strong>, to ensure clearance. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Chloroquine:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Chloroquine has activity against the blood stages of <em>Plasmodium ovale</em>, <em>Plasmodium malariae</em>, and susceptible strains of <em>Plasmodium vivax and Plasmodium falciparum</em>. It has no activity against dormant pathogens. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Arthemether:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Arthemether is an artemisinin derivative that acts rapidly to kill the blood stages of all Plasmodium species. However, it has no activity against parasites in the dormant stage of infection. &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Primaquine:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Ivermectin:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Ivermectin is an anthelmintic drug approved for oral treatment of onchocerciasis and strongyloidiasis. It is not effective in the treatment of malaria. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Mefloquine:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Mefloquine is a highly effective blood schizonticide that is thought to work by inhibiting protein synthesis in Plasmodium species. It has no activity against dormant pathogens. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 60-year-old woman comes to the emergency department because of worsening shortness of breath for the past month. The patient states that she is unable to perform simple activities without getting short of breath. Today, the patient was unable to climb the stairs and decided to come to the emergency department. Past medical history is significant for hypertension, hyperlipidemia, and type 2 diabetes mellitus complicated by end-stage renal disease managed with dialysis. Current medications include insulin, metformin, lisinopril and atorvastatin. The patient is non-adherent to her medications. Temperature is 36.7&#176;C (98.0&#176;F), pulse is 65/min, respirations are 20/min and blood pressure is 134/83 mmHg. The EKG and chest x-ray are within normal limits. Laboratory results are shown below. There are no signs of active bleeding. The patient is given a unit of packed red blood cells with an appropriate response in her repeat hemoglobin. The physician is considering starting the patient on a medication commonly used to improve hemoglobin levels. Which of the following is a side-effect of this long-term therapy? &#160;<br><br><table><tbody><tr><td><strong> Laboratory value</strong>&#160;</td><td><strong> Result&#160;</strong></td></tr><tr><td>&#160;Hemoglobin&#160;</td><td>&#160;6.8 g/dL&#160;</td></tr><tr><td>&#160;Hematocrit&#160;</td><td>&#160;21%&#160;</td></tr><tr><td>&#160;Leukocyte count&#160;</td><td>&#160;5,000/mm<span>3</span>&#160;</td></tr><tr><td>&#160;Platelet count &#160;</td><td>&#160; 200,000/mm<span>3</span>&#160;</td></tr><tr><td>&#160;Mean corpuscular volume&#160;</td><td>&#160;81 &#956;m<span>3</span>&#160;</td></tr><tr><td>&#160;Serum&#160;</td><td>&#160;</td></tr><tr><td>&#160;Creatinine &#160;</td><td>&#160;2.5 g/dL&#160;</td></tr><tr><td>&#160;BUN&#160;</td><td>&#160;29 mg/dL&#160;</td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "choices": [
        {
          "id": 1,
          "text": "Capillary leak syndrome"
        },
        {
          "id": 2,
          "text": "Bone pain"
        },
        {
          "id": 3,
          "text": "Hypertension"
        },
        {
          "id": 4,
          "text": "Cushing syndrome"
        },
        {
          "id": 5,
          "text": "Gingival hyperplasia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "This patient is presenting with end-stage renal disease and severe anemia which should be managed with erythropoietin. &#160;A common side-effect of <strong>erythropoietin&#160;</strong>is <strong>hypertension</strong>. &#160; <br><br>Kidneys have a native function of producing erythropoietin (EPO) to stimulate the bone marrow to produce red blood cells. In patients with chronic kidney disease or end-stage renal disease, there is insufficient production of EPO, resulting in anemia. &#160;The medication <strong>epoetin&#160;</strong>is a <strong>recombinant erythropoietin</strong> (EPO), which <strong>stimulates the production of new red blood cells.</strong> Epoetin is an incredibly powerful drug for the treatment of anemia especially when the anemia is due to<strong>&#160;chronic renal failure,&#160;</strong>where the damaged kidneys cannot produce enough EPO. It is also effective in correcting anemias caused by other medications such as <strong>zidovudine</strong>, as well as anemia caused by certain cancers like leukemia, and anemia in critically ill patients known as <strong>anemia of chronic disease. &#160;&#160;</strong><br><br>It is important to note that several weeks of therapy are required before erythrocyte counts rise, so it is not an alternative to transfusing blood. In general, epoetin is a well tolerated medication, but it could cause <strong>hypertension&#160;</strong>and increase clot formation since there are more red blood cells in the blood. &#160;<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/hl0Ks4b9RfO-ETPVeBjLbpE_QL_RODA1/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Capillary leak syndrome:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Capillary leak syndrome, where fluids leak from the capillaries into the surrounding tissue causing severe edema, can be caused by therapy with sargramostim, a synthetic version of granulocyte-monocyte-colony stimulating factor (GM-CSF). It is often used to boost myeloid precursor production and maturation. This patient is most likely started on erythropoietin.&#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Bone pain:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Bone pain is a rare side effect of filgrastim, which results from high neutrophil production in the bone marrow. Filgrastim is a recombinant granulocyte-colony stimulating factor and is used to correct neutropenia. It is not effective in treating anemia secondary to chronic kidney disease.&#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Hypertension:</strong><br><span style='opacity:0.9'><strong>Correct: </strong>See Main Explanation.&#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Cushing syndrome:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Cushing syndrome is an adverse effect associated with the use of glucocorticoid therapy which is often used in the management of many autoimmune and inflammatory disorders, adrenal insufficiency and asthma. It is not effective in anemia secondary to chronic kidney disease.&#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Gingival hyperplasia:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Gingival hyperplasia is a common side effect of cyclosporine, a calcineurin inhibitor, used in the management of psoriasis and rheumatoid arthritis. &#160;It is not effective in anemia secondary to chronic kidney disease.&#160;&#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 57-year-old man presents to the primary care clinic for a routine physical. He reports worsening fatigue for the last five weeks as well as a worsening cough for three months. Past medical history is significant for chronic obstructive pulmonary disease (COPD) and hypercholesterolemia for which he takes atorvastatin. He has a 40-pack-year smoking history. He does drink alcohol or use recreational drugs. The patient has lost 15 pounds since his last visit six months ago. He has not had blood in the stool. Temperature is 36.1&#176;C (97&#176;F), pulse is 91/min, respiratory rate is 15/min, blood pressure is 126/74 mmHg, and oxygen saturation is 98% on room air. On physical examination, he appears pale with mild conjunctival pallor. Pulmonary auscultation reveals expiratory wheezes bilaterally. Cardiac exam shows tachycardia but is otherwise unremarkable. A complete blood count (CBC) is obtained with results shown below. Which of the following additional test results would be most consistent with the likely diagnosis? &#160;<br><br><table><tbody><tr><td><strong>Laboratory value</strong><br></td><td><strong>Result</strong><br></td></tr><tr><td>Hemoglobin<br></td><td>9.8 g/dL<br></td></tr><tr><td>Hematocrit<br></td><td>29.4%<br></td></tr><tr><td>Mean corpuscular volume<br></td><td>75 fL<br></td></tr><tr><td>Reticulocyte count<br></td><td>0.7%<br></td></tr><tr><td>Ferritin<br></td><td>450 &#181;g/L<br></td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br>",
      "choices": [
        {
          "id": 1,
          "text": "Elevated total iron-binding capacity (TIBC) and low serum iron concentration"
        },
        {
          "id": 2,
          "text": "Decreased total iron-binding capacity (TIBC) and low serum iron concentration"
        },
        {
          "id": 3,
          "text": "Elevated total iron-binding capacity (TIBC) and basophilic stippling of red blood cells"
        },
        {
          "id": 4,
          "text": "Elevated total iron-binding capacity (TIBC) and high serum iron concentration"
        },
        {
          "id": 5,
          "text": "Normal total iron-binding capacity (TIBC) and high serum iron concentration"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/-e1XBos-T0qkThUgN1NtPL7LQkO3PIbx/_.png\"></div><br>This patient presents with fatigue, a 15-lb unintentional weight loss, new cough, as well as COPD, and a 40-pack-year smoking history. He likely has <strong>anemia of chronic disease</strong> secondary to <strong>lung cancer</strong>.<br><br>Anemia of chronic disease (also known as anemia of inflammation) (ACD/AI) is a <strong>microcytic or normocytic anemia</strong> that can be seen in disease states that cause chronic inflammation. ACD/AI occurs in the setting of chronic conditions, such as malignancy, infection, or autoimmune diseases. Chronic inflammation dysregulates iron homeostasis, primarily by increasing <strong>hepcidin&#160;</strong>and other cytokines, to <strong>prevent iron release</strong>. This sequestration results in <strong>low serum iron, high ferritin</strong> (because iron stores are full and because of chronic inflammation), l<strong>ow transferrin saturation (TSAT), and low total iron-binding capacity (TIBC)</strong> (because iron is unavailable).<br><br>Results from iron studies (i.e. serum iron, ferritin, transferrin saturation [TSAT], and total iron-binding capacity [TIBC]) can help to narrow down the etiology of <strong>microcytic anemia</strong> as indicated in the table below. <br>&#160;<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/Q02hkN7eRtCR__ehjWgKoRq-Q0WNP8pK/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Elevated total iron-binding capacity (TIBC) and low serum iron concentration:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: These findings are consistent with iron deficiency anemia. This patient&#8217;s history is highly suggestive of a pulmonary malignancy, which can be associated with anemia of chronic disease, and would present with a decreased TIBC. &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Decreased total iron-binding capacity (TIBC) and low serum iron concentration:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Elevated total iron-binding capacity (TIBC) and basophilic stippling of red blood cells:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Microcytic anemia with basophilic stippling is associated with lead poisoning and sideroblastic anemia. However, anemia of chronic disease is more likely in this patient with unintentional weight loss, cough, COPD, and a significant smoking history. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Elevated total iron-binding capacity (TIBC) and high serum iron concentration:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Elevated TIBC is associated with iron deficiency or lead poisoning. Decreased TIBC is seen in anemia of chronic disease. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Normal total iron-binding capacity (TIBC) and high serum iron concentration:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: These results are consistent with sideroblastic anemia, which is most commonly due to chronic alcohol use or heavy metal poisoning. This patient does not have any apparent exposures, and his presentation is more consistent with anemia of chronic disease secondary to malignancy. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 65-year-old man presents to the primary care clinic for his routine visit. In the past six months, he has noticed fatigue, diffuse itchiness, and decreased urine production. He has a 20-year history of diabetes and has not seen a doctor since he lost insurance coverage six years ago. He has not had blood in the stool. Temperature is 36.1&#176;C (97&#176;F), pulse is 88/min, respiratory rate is 15/min, and blood pressure is 175/95 mmHg. On physical examination, he has conjunctival pallor and 1+ pitting edema in both lower extremities up to the knees. Cardiopulmonary and abdominal examinations are unremarkable. Results of laboratory testing are shown below. Which of the following is the best next step for determining the cause of anemia in this patient? &#160;<br><br><table><tbody><tr><td><strong>Laboratory value</strong><br></td><td><strong>Result</strong><br></td></tr><tr><td>Hemoglobin<br></td><td>9.4 g/dL<br></td></tr><tr><td>Hematocrit<br></td><td>28%<br></td></tr><tr><td>Mean corpuscular volume<br></td><td>85 fL<br></td></tr><tr><td>Reticulocyte count<br></td><td>0.4%<br></td></tr><tr><td>Sodium<br></td><td>134 mEq/L<br></td></tr><tr><td>Potassium<br></td><td>5.3 mEq/L<br></td></tr><tr><td>Blood urea nitrogen<br></td><td>77 mg/dL<br></td></tr><tr><td>Creatinine<br></td><td>6.3 mg/dL (previously 1.7 mg/dL)<br></td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br>",
      "choices": [
        {
          "id": 1,
          "text": "Calculate estimated glomerular filtration rate (eGFR)"
        },
        {
          "id": 2,
          "text": "Schedule bone marrow aspiration"
        },
        {
          "id": 3,
          "text": "Check blood lead level"
        },
        {
          "id": 4,
          "text": "Check serum B12 and folate levels"
        },
        {
          "id": 5,
          "text": "Assess peripheral smear"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<strong>Anemia of Chronic Kidney Disease</strong><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/hPQvM0XQRB_UYvQpjH2QzsoiT_qj-h5J/_.png\"></div><br>This patient with long-standing diabetes presents with fatigue, pruritus, edema, and hypertension. Labs show <strong>normocytic anemia, uremia, </strong>and <strong>elevated creatinine</strong>. Together, these findings suggest <strong>chronic kidney disease (CKD) secondary to diabetes</strong>. Chronic kidney disease can lead to decreased production of erythropoietin and a normocytic anemia. The first step for determining the cause of anemia in this patient is to <strong>calculate the estimated glomerular filtration rate (eGFR)</strong>. <br><br><strong>Anemia of CKD</strong> is a common comorbidity that results from <strong>reduced production of erythropoietin</strong> by the kidneys as well as a <strong>shortened red blood cell lifespan</strong>. This usually presents as a <strong>normocytic, normochromic</strong> anemia. CKD can be diagnosed as the primary etiology of anemia only after <strong>excluding other causes</strong>. Evaluation includes a complete blood count with differential, iron studies, and testing for the presence of blood in stool. When mean corpuscular volume is increased, B12 and folate levels should also be checked. Therapy with erythropoietin-stimulating agents should only be initiated following a negative workup of non-renal causes and confirmation of CKD. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Calculate estimated glomerular filtration rate (eGFR):</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Schedule bone marrow aspiration:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Examination of the bone marrow can identify etiologies directly affecting hematopoiesis, such as aplasia or myelodysplastic syndrome. This patient&#8217;s presentation is consistent with anemia of chronic kidney disease, which impacts the stimulation of hematopoiesis. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Check blood lead level:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Lead poisoning results in microcytic anemia, not normocytic anemia. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Check serum B12 and folate levels:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Vitamin B12 and folate deficiencies both result in macrocytic anemia. This patient has normocytic anemia. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Assess peripheral smear:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Looking at red blood cell morphology via peripheral smear can be helpful in differentiating causes of microcytosis and macrocytosis. This patient has normocytic anemia. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    }
  ]
}